Invitation to presentation of Xbrane Biopharma’s interim report January – September 2022 on October 28, 2022
Other Corporate Information
Xbrane Biopharma AB invites to a teleconference for investors, analysts and media on Friday, October 28th, 2022, at 14.00 a.m. CET. Xbrane will publish the company’s interim report January – September 2022, on Friday, October 28, 2022, at 8.00 a.m. CET.
Martin Åmark, CEO, and Anette Lindqvist, CFO/IR, will present the interim report January – September 2022, followed by a Q&A session. The presentation will be in English. To attend, please follow the link below: